deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT04330183

Low Dose Ketamine and Acute Pain Crisis (LDK-SCD)

Low Dose Ketamine for Acute Pain Crisis in Patients With Sickle Cell Disease

Sponsor: Rhode Island Hospital

Conditions Sickle Cell Crisis
Interventions Ketamine Normal Saline
Updated 6 times since 2020 Last updated: Dec 22, 2021 Started: Jul 1, 2020 Primary completion: Oct 1, 2021 Completion: Oct 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Sickle Cell Crisis, this trial is completed. The trial is conducted by Rhode Island Hospital and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~May 2020 – ~Aug 2020 · 3 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotRecruiting~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2022 — Jul 2024 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  4. Jan 2021 — Jan 2022 [monthly]

    Recruiting PHASE4

  5. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

  1. May 2020 — Aug 2020 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rhode Island Hospital
Data source: Rhode Island Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations